Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOPINAVIR vs LORAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOPINAVIR vs LORAZEPAM: Safety Overview

Metric LOPINAVIR LORAZEPAM
Total FAERS Reports 1,242 33,404
Deaths Reported 162 6,187
Death Rate 13.0% 18.5%
Hospitalizations 193 15,431
Average Patient Age 39.2 yrs 49.8 yrs
% Female Patients 32.7% 60.8%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer AbbVie Inc. Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAMUSCULAR
Marketing Status N/A Prescription